Skip to main content
. 2011 Jul 16;26(12):1465–1470. doi: 10.1007/s11606-011-1796-4

Figure 2.

Figure 2

a. Trends in use of inhaled steroids, long-acting β2-agonists, and steroid/ β2-agonist combination therapy (NAMCS). “Long-acting β2-agonist/steroids" depicts both fixed dose combinations and concurrent use of separate therapies. b. Trends in use of inhaled steroids, long-acting β2-agonists, and steroid/β2-agonist combination therapy (NDTI). “Long-acting β2-agonist/steroids" depicts both fixed dose combinations and concurrent use of separate therapies.